Share on Facebook
Share on Twitter
Share on LinkedIn

Implanted pumps made by Medtronic Inc. (MDT) to deliver painkillers and drugs may corrode and fail, said U.S. regulators who requested a meeting to discuss the issue.

The Food and Drug Administration letter stems from an inspection at the neuromodulation unit for Minneapolis-based Medtronic that concluded May 9 and found corrosion in the SynchroMed II pump can cause the motor to stall or seize.

Click here to read more.